Because an estimated one in 10 Americans lives with a rare disease, ARUP is committed to investing in the diagnostic research and innovation that will help bring them answers.
The award recognizes the work ARUP does to educate, advocate, and innovate while continuously pushing to improve patient care.
ARUP and other clinical labs anxiously await a decision by a federal court in Texas about whether the FDA overstepped its statutory authority.
Fallon Williams and her daughter have similar heart conditions, which do not have a known genetic cause. Williams hopes whole genome sequencing can provide answers and improve cardiac care for all.
February is National Cancer Prevention Month. ARUP Consult provides guidance on hereditary cancer germline genetic testing for early detection and management of inherited cancer syndromes.
The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.
A new ARUP white paper highlights the potential indirect costs of outsourcing laboratories and suggests ways for clinical laboratories to demonstrate their value to the health system.
ARUP Consult offers expert guidance on laboratory testing for influenza, RSV, and COVID-19, helping clinicians order the right tests at the right time.